Spectral AI, Inc. operates as a predictive AI company. The Company focuses on medical diagnostics for faster and more accurate treatment decisions in wound care for burn, DFU, and future clinical applications. Spectral AI serves customers in the United States.

S-3 | Registration statement for specified transactions by certain issuers

424B5 | Prospectus

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Spectral AI (MDAI US)

S-3 | Registration statement for specified transactions by certain issuers

424B5 | Prospectus

Quarterly Report (Form 10-Q | Period ending 2024-09-30)

US SEC Form 25-NSE for Rosecliff Acquisition Corp I

US SEC Form 425 for Rosecliff Acquisition Corp I

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)